Celularity Company Insiders

CELU Stock  USD 1.25  0.01  0.79%   
Celularity's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Celularity suggests that vertually all insiders are extremely bullish. Celularity employs about 123 people. The company is managed by 17 executives with a total tenure of roughly 287 years, averaging almost 16.0 years of service per executive, having 7.24 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2024-01-12Kok Thay LimAcquired 2141098 @ 2.5View
2023-10-05Robert J HaririAcquired 935758 @ 1.6View
2023-09-29Robert J HaririAcquired 906453 @ 1.7View
2022-11-30Robert J HaririAcquired 1000 @ 17.2View
2022-11-28Robert J HaririAcquired 4000 @ 17.4View
Monitoring Celularity's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Management Team Effectiveness

The company has return on total asset (ROA) of (0.2503) % which means that it has lost $0.2503 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (63.6724) %, meaning that it created substantial loss on money invested by shareholders. Celularity's management efficiency ratios could be used to measure how well Celularity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.47 in 2026. Return On Capital Employed is likely to drop to -0.59 in 2026. Total Current Liabilities is likely to drop to about 40.3 M in 2026. Liabilities And Stockholders Equity is likely to drop to about 145 M in 2026
Common Stock Shares Outstanding is likely to gain to about 26.4 M in 2026. Net Income Applicable To Common Shares is likely to gain to about 17.1 M in 2026
Celularity holds a total of 28.84 Million outstanding shares. Celularity retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2019-03-31
Previous Quarter
24 M
Current Value
26.3 M
Avarage Shares Outstanding
12.6 M
Quarterly Volatility
8.5 M
 
Covid
Dividends Paid is likely to drop to about 31.3 M in 2026. Dividend Paid And Capex Coverage Ratio is likely to drop to -37.57 in 2026. Common Stock Shares Outstanding is likely to gain to about 26.4 M in 2026. Net Income Applicable To Common Shares is likely to gain to about 17.1 M in 2026.

Celularity Workforce Comparison

Celularity is rated third in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 714. Celularity retains roughly 123 in number of employees claiming about 17% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.43) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.43.

Celularity Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Celularity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Celularity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Celularity insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Celularity Notable Stakeholders

A Celularity stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Celularity often face trade-offs trying to please all of them. Celularity's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Celularity's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Celularity Management Performance

The success or failure of an entity such as Celularity often depends on how effective the management is. Celularity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Celularity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Celularity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.45)(0.47)
Return On Capital Employed(0.56)(0.59)
Return On Assets(0.50)(0.53)
Return On Equity(7.53)(7.91)
Please note, the imprecision that can be found in Celularity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Celularity. Check Celularity's Beneish M Score to see the likelihood of Celularity's management manipulating its earnings.

Celularity Workforce Analysis

Traditionally, organizations such as Celularity use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Celularity within its industry.

Celularity Manpower Efficiency

Return on Celularity Manpower

Revenue Per Employee440.8K
Revenue Per Executive3.2M
Net Loss Per Employee470.7K
Net Loss Per Executive3.4M

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.